Integrated BioPharma (OTCMKTS:INBP) Posts Quarterly Earnings Results

Integrated BioPharma (OTCMKTS:INBP) posted its earnings results on Friday. The company reported $0.01 earnings per share (EPS) for the quarter, reports. Integrated BioPharma had a negative return on equity of 0.62% and a negative net margin of 0.23%. The firm had revenue of $12.75 million for the quarter.

Integrated BioPharma Price Performance

Shares of INBP stock opened at $0.23 on Friday. The business’s fifty day moving average is $0.20 and its 200 day moving average is $0.21. Integrated BioPharma has a twelve month low of $0.16 and a twelve month high of $0.30.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.